ABUS vs REGN: Which Stock is Better?
Side-by-side comparison of Arbutus Biopharma Corp and Regeneron Pharmaceuticals Inc in 2026
ABUS
Arbutus Biopharma Corp
—
REGN
Regeneron Pharmaceuticals Inc
$664.52
Key Metrics Comparison
| Metric | ABUS | REGN | Winner |
|---|---|---|---|
| Market Cap | $882.99M | $59.10B | REGN |
| P/E Ratio | 5.39 | 13.91 | ABUS |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABUS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABUS or REGN a better investment?
Comparing ABUS and REGN: Arbutus Biopharma Corp has a market cap of $882.99M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABUS and REGN?
ABUS (Arbutus Biopharma Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABUS or REGN?
Based on P/E ratios, ABUS trades at a lower multiple (5.4x vs 13.9x).
Which is growing faster: ABUS or REGN?
Both ABUS and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABUS or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABUS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $882.99M for ABUS.
Should I buy ABUS or REGN in 2026?
Both ABUS and REGN have investment merit. ABUS trades at $N/A while REGN trades at $664.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABUS and REGN stock?
Key differences: Market Cap ($882.99M vs $59.10B), P/E Ratio (5.4x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABUS or REGN in 2026?
The choice between ABUS and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABUS and REGN?
ABUS (Arbutus Biopharma Corp) has a market cap of $882.99M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.